Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

RxSight continues to expand access to the Light Adjustable Lens through its growing network of trained surgeons and certified practices across the United States and select international markets. The ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded ...

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

Complex cataract surgery presents unique challenges when capsular support is absent or compromised by trauma, ...

Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence. Its ...

Dr. Yangzhi Zhu from the Terasaki Institute for Biomedical Innovation has published a research paper titled "Real-time ...

ReportsnReports.com adds the global intraocular lens (IOL) market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly ...